Bill Gates on HIV

Bill Gates considers the transformation in fighting HIV/AIDS one of the most remarkable achievements in global health, though he stresses that treatment alone is unsustainable without robust prevention strategies. He champions scientific innovation, particularly in developing longer-acting prevention methods like injectable pre-exposure prophylaxis (PrEP) such as lenacapavir, which require less frequent dosing than daily pills. The Gates Foundation actively funds research into these new tools, which aim to overcome practical barriers like clinic access, adherence challenges, and stigma faced by those needing protection.

His efforts focus on ensuring that scientific breakthroughs reach the most vulnerable populations equitably and affordably, often through partnerships with manufacturers to drive down the cost of generic drugs. He has also emphasized the need for continued research toward an eventual HIV vaccine, viewing these advances as creating multiple layers of protection rather than diminishing the need for a cure. Furthermore, he frequently draws lessons from the AIDS fight—especially around global distribution systems—to address challenges in other pandemics.